{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06032559",
            "orgStudyIdInfo": {
                "id": "Pro2022001626"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DA056537",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DA056537"
                }
            ],
            "organization": {
                "fullName": "Rutgers, The State University of New Jersey",
                "class": "OTHER"
            },
            "briefTitle": "Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment",
            "officialTitle": "Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment for Opioid Use Disorder and Chronic Pain",
            "acronym": "IMPOWR-MORE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "implementation-and-effectiveness-of-mindfulness-oriented-recovery-enhancement-as-an-adjunct-to-methadone-treatment"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-04",
            "studyFirstSubmitQcDate": "2023-09-04",
            "studyFirstPostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-07",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Nina A. Cooperman, Psy. D.",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "Rutgers, The State University of New Jersey"
            },
            "leadSponsor": {
                "name": "Rutgers, The State University of New Jersey",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                },
                {
                    "name": "University of Utah",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This hybrid implementation-effectiveness trial will evaluate Mindfulness-Oriented Recovery Enhancement (MORE) for patients with opioid use disorder receiving methadone treatment (MT). The investigators will also assess barriers and facilitators to integrating MORE into methadone treatment, and evaluate the impact of a sustainable train-the-trainer model on provider burden, intervention fidelity, intervention engagement, and outcomes. Participants will be assigned to a higher intensity MORE implementation strategy, a minimal intensity implementation strategy consisting of a simple, scripted mindfulness practice (SMP) extracted from the MORE treatment manual with minimal training and feedback and no supervision, or methadone treatment as usual (TAU). We aim to:\n\n* Examine barriers and facilitators to the implementation of MORE and SMP in MT and evaluate strategies for optimizing training, fidelity, and engagement.\n* Evaluate the effectiveness and treatment fidelity of a higher intensity MORE implementation strategy versus a lower intensity, scripted mindfulness practice (SMP) implementation strategy as an adjunct to methadone TAU or methadone TAU, only. Outcomes include opioid and other drug use, craving, MT discontinuation, depression, anxiety, and physical pain (secondary outcomes) than patients randomized to TAU."
        },
        "conditionsModule": {
            "conditions": [
                "Opioid Use",
                "Pain"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 450,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "MORE",
                    "type": "EXPERIMENTAL",
                    "description": "Eight group sessions of Mindfulness-Oriented Recovery Enhancement plus methadone treatment as usual (TAU)",
                    "interventionNames": [
                        "Behavioral: MORE"
                    ]
                },
                {
                    "label": "Scripted Mindfulness Practice (SMP)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Eight group sessions of scripted mindfulness practice plus TAU.",
                    "interventionNames": [
                        "Behavioral: SMP"
                    ]
                },
                {
                    "label": "Treatment-as-Usual",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Methadone treatment as usual.",
                    "interventionNames": [
                        "Other: TAU"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "MORE",
                    "description": "MORE plus TAU",
                    "armGroupLabels": [
                        "MORE"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "SMP",
                    "description": "SMP plus TAU",
                    "armGroupLabels": [
                        "Scripted Mindfulness Practice (SMP)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "TAU",
                    "description": "TAU only",
                    "armGroupLabels": [
                        "Treatment-as-Usual"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Days of drug use",
                    "description": "mber of days of drug use as measured by self-reported days of use and biochemically verified use via drug screen.",
                    "timeFrame": "Baseline through 52 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Chronic Pain",
                    "description": "Chronic pain measured by the Brief Pain Inventory Short Form (range 0-10, with higher scores indicating worse pain).",
                    "timeFrame": "Baseline through 52 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* English-speaking\n* age \u226518\n* currently on methadone\n* persistent or recurring pain that has lasted for a duration of 3 months of longer.\n\nExclusion Criteria:\n\n* severe cognitive impairment (score \\>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)\n* suicidal risk (score \u22657 on Suicidal Behaviors Questionnaire)\n* inability to attend or fully participate in intervention sessions or assessments\n* previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33 studies).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nina Cooperman, PsyD",
                    "role": "CONTACT",
                    "phone": "732-235-8569",
                    "email": "cooperna@rwjms.rutgers.edu"
                },
                {
                    "name": "Eric Garland, PhD",
                    "role": "CONTACT",
                    "phone": "801-581-3826",
                    "email": "eric.garland@socwk.utah.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Eric Garland, Ph",
                    "affiliation": "Rutgers Robert Wood Johnson Medical School",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Rutgers Robert Wood Johnson Medical School",
                    "status": "RECRUITING",
                    "city": "New Brunswick",
                    "state": "New Jersey",
                    "zip": "08901",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nina Cooperman",
                            "role": "CONTACT",
                            "phone": "732-235-8569",
                            "email": "cooperna@rwjms.rutgers.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.48622,
                        "lon": -74.45182
                    }
                },
                {
                    "facility": "University of Utah",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "04108",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ericc Garland, PhD",
                            "role": "CONTACT",
                            "phone": "801-581-3826",
                            "email": "Eric.Garland@socwk.utah.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "All participant data collected during the trial will be shared after de-identification.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR"
            ],
            "timeFrame": "Beginning 3 months and ending five years after study publication.",
            "accessCriteria": "Researchers who provide a methodologically sound proposal."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M29442",
                    "name": "Chronic Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M11671",
                    "name": "Methadone",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnTuAg",
                    "name": "Antitussive Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                }
            ]
        }
    },
    "hasResults": false
}